Multiple Assemblies exist for SMTL entry 3ig6
Low molecular weigth human Urokinase type Plasminogen activator 2-[6-(3'-Aminomethyl-biphenyl-3-yloxy)-4-(3-dimethylamino-pyrrolidin-1-yl)-3,5-difluoro-pyridin-2-yloxy]-4-dimethylamino-benzoic acid complex; X-RAY DIFFRACTION 1.83 Å

	SMTL ID 3ig6.1 Ligands 2-[(6-{[3'-(aminomethyl)biphenyl-3-yl]oxy}-4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-3,5-difluoropyridin-2-yl)oxy]-4-(dimethylamino)benzoic acid Polypeptides Urokinase-type plasminogen activator; Urokinase-type plasminogen activator Oligo-state hetero-1-1-mer
	SMTL ID 3ig6.2 Ligands 2-[(6-{[3'-(aminomethyl)biphenyl-3-yl]oxy}-4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-3,5-difluoropyridin-2-yl)oxy]-4-(dimethylamino)benzoic acid; PHOSPHATE ION Polypeptides Urokinase-type plasminogen activator; Urokinase-type plasminogen activator Oligo-state hetero-1-1-mer
	SMTL ID 3ig6.3 Ligands 2-[(6-{[3'-(aminomethyl)biphenyl-3-yl]oxy}-4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-3,5-difluoropyridin-2-yl)oxy]-4-(dimethylamino)benzoic acid; PHOSPHATE ION Polypeptides Urokinase-type plasminogen activator; Urokinase-type plasminogen activator Oligo-state hetero-4-4-mer
	SMTL ID 3ig6.4 Ligands 2-[(6-{[3'-(aminomethyl)biphenyl-3-yl]oxy}-4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-3,5-difluoropyridin-2-yl)oxy]-4-(dimethylamino)benzoic acid; PHOSPHATE ION Polypeptides Urokinase-type plasminogen activator; Urokinase-type plasminogen activator Oligo-state hetero-2-2-mer